Hu Chu-Ting, Shao Yi-Duo, Liu Yi-Zhang, Xiao Xuan, Cheng Zhe-Bin, Qu Shun-Lin, Huang Liang, Zhang Chi
Institute of Cardiovascular Disease, Key Lab for Arteriosclerology of Hunan Province, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, People's Republic of China; Research Lab for Clinical & Translational Medicine, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, People's Republic of China; Departments of Medical Laboratory, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, People's Republic of China.
Institute of Cardiovascular Disease, Key Lab for Arteriosclerology of Hunan Province, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, People's Republic of China; Research Lab for Clinical & Translational Medicine, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, People's Republic of China; Departments of Stomatology, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, People's Republic of China.
Clin Chim Acta. 2021 Aug;519:101-110. doi: 10.1016/j.cca.2021.04.012. Epub 2021 Apr 20.
Vascular calcification (VC), which is closely associated with significant mortality in cardiovascular disease, chronic kidney disease (CKD), and/or diabetes mellitus, is characterized by abnormal deposits of hydroxyapatite minerals in the arterial wall. The impact of oxidative stress (OS) on the onset and progression of VC has not been well described. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases, xanthine oxidases, myeloperoxidase (MPO), nitric oxide synthases (NOSs), superoxide dismutase (SOD) and paraoxonases (PONs) are relevant factors that influence the production of reactive oxygen species (ROS). Furthermore, excess ROS-induced OS has emerged as a critical mediator promoting VC through several mechanisms, including phosphate balance, differentiation of vascular smooth muscle cells (VSMCs), inflammation, DNA damage, and extracellular matrix remodeling. Because OS is a significant regulator of VC, antioxidants may be considered as novel treatment options.
血管钙化(VC)与心血管疾病、慢性肾脏病(CKD)和/或糖尿病的显著死亡率密切相关,其特征是动脉壁中羟基磷灰石矿物质的异常沉积。氧化应激(OS)对VC发生和进展的影响尚未得到充分描述。烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶、黄嘌呤氧化酶、髓过氧化物酶(MPO)、一氧化氮合酶(NOSs)、超氧化物歧化酶(SOD)和对氧磷酶(PONs)是影响活性氧(ROS)产生的相关因素。此外,过量ROS诱导的OS已成为通过多种机制促进VC的关键介质,这些机制包括磷酸盐平衡、血管平滑肌细胞(VSMC)分化、炎症、DNA损伤和细胞外基质重塑。由于OS是VC的重要调节因子,抗氧化剂可能被视为新的治疗选择。